Management of Hematemesis with Shivering
A patient presenting with hematemesis and shivering requires immediate resuscitation with large-bore IV access, fluid administration targeting systolic blood pressure of 80-100 mmHg until bleeding is controlled, urgent endoscopy within 24 hours, and treatment of the shivering with meperidine (12.5-50 mg) which has potent anti-shivering properties while simultaneously addressing the underlying bleeding source. 1, 2
Immediate Stabilization and Assessment
Hemodynamic Resuscitation:
- Secure large-bore intravenous access (ideally 8-Fr central access in adults) immediately to allow for rapid fluid resuscitation 1
- Administer high FiO2 to ensure adequate oxygenation 1
- Target systolic blood pressure of 80-100 mmHg until major bleeding has been controlled 2, 1
- Actively warm the patient and all transfused fluids to prevent hypothermia, which can worsen coagulopathy 1
Critical Laboratory Studies:
- Obtain baseline complete blood count, prothrombin time (PT), activated partial thromboplastin time (aPTT), and Clauss fibrinogen 1
- Measure serum lactate and base deficit to estimate and monitor the extent of bleeding and shock 1
- Do not rely on single hemoglobin/hematocrit measurements as isolated markers for bleeding severity, as they may not reflect acute blood loss 1, 2
Management of Shivering
Pharmacologic Anti-Shivering Therapy:
- Meperidine 12.5-50 mg is the preferred agent due to its potent anti-shivering properties 2
- Be aware that meperidine has an active metabolite associated with neurotoxicity and decreases seizure threshold 2
- Alternative agents include magnesium sulfate (2-4 g bolus, then 1 g/h every 2-4 hours) as an adjunct 2
- Consider ondansetron 4-8 mg every 4-8 hours in a preventative manner, though effects are limited 2
Non-Pharmacologic Measures:
Blood Product Administration
Transfusion Strategy:
- Transfuse packed red blood cells to maintain hemoglobin above 7 g/dL in most patients 1
- Consider a higher transfusion threshold of 9 g/dL in patients with massive bleeding, significant cardiovascular comorbidities, or when therapeutic interventions may be delayed 1
- For massive hemorrhage, administer warmed blood and blood components 1
- Use blood products in order of availability: O-type blood, group-specific blood, then cross-matched blood 1
Urgent Endoscopic Management
Timing and Approach:
- Perform urgent endoscopic assessment within 24 hours of presentation after initial stabilization 1, 3
- The success rate is highest if endoscopy is performed within the first 36 hours of the onset of bleeding 4
- Insert a nasogastric tube to protect the airway, decompress the stomach, and assess ongoing bleeding 1
Endoscopic Interventions:
- Implement appropriate endoscopic hemostatic interventions based on findings (injection, thermal, or mechanical methods) 1, 3
- Epinephrine injection should always be used in conjunction with another method to increase success of achieving hemostasis 3
Pharmacologic Adjuncts:
- Administer intravenous proton pump inhibitors in the acute setting to decrease the probability of high-risk stigmata seen during endoscopy 3
- Consider pro-kinetic agents 30 minutes to one hour before endoscopy to aid in diagnosis 3
When Endoscopy Fails or Is Unavailable
Alternative Interventions:
- Consider interventional radiology angiographic embolization techniques when endoscopy is unsuccessful 1
- For massive, life-threatening bleeding, surgical intervention may be necessary 1
Critical Pitfalls to Avoid
- Avoid delays between presentation and intervention for patients requiring urgent bleeding control 1, 2
- Do not rely solely on blood pressure as an indicator of blood loss, as some patients compensate well despite significant hemorrhage 1
- Recognize that 65% of hemorrhages subside spontaneously, but 25% bleed recurrently and 75% of renewed bleeding occurs within two days after the initial hemorrhage 4
- Be aware that bloody hematemesis is not necessarily more severe than coffee-grounds emesis, though it is associated with modestly higher rates of hemostatic intervention and rebleeding 5